바이오마린제약(주)
MX ˙ BMV ˙ US09061G1013
SecurityMX:BMRN / BioMarin Pharmaceutical Inc.
InstitutionWalleye Trading LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Walleye Trading LLC ownership in BMRN / BioMarin Pharmaceutical Inc.

On February 13, 2026 - Walleye Trading LLC filed a 13F-HR form disclosing ownership of 0 shares of BioMarin Pharmaceutical Inc. (MX:BMRN) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 4,407 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -100.00% during the quarter.

Walleye Trading LLC has a history of taking positions in derivatives of the underlying security (BMRN) in the form of stock options. The firm currently holds call options representing 61,100 of underlying shares valued at $3,451,539 USD and put options representing 39,500 of underlying shares valued at $2,231,355 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:BMRN / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -4,407 -100.00 0 -100.00
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,407 3,307 300.64 239 296.67 0.0004
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,100 -2,183 -66.49 60 -74.14 0.0001
2025-05-14 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,283 -5,429 -62.32 232 -59.44 0.0005
2025-02-13 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,712 -18,167 -67.59 573 -69.72 0.0012
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 26,879 -66,551 -71.23 1,889 -75.44 0.0040
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 93,430 84,712 971.69 7,692 910.78 0.0182
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,718 -12,865 -59.61 761 -63.43 0.0016
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 21,583 7,555 53.86 2,081 67.69 0.0045
2023-11-21 2023-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 14,028 -13,894 -49.76 1,241 -48.72 0.0033
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 14,028 -13,894 1,241 0.0033
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 27,922 27,922 2,420 0.0073
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -12,174 -100.00 0 -100.00
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,174 12,174 1,032 0.0031
2022-08-08 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -5,142 -100.00 0 -100.00
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,142 2,273 79.23 396 56.52 0.0013
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,869 -3,602 -55.66 253 -49.40 0.0008
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,471 1,251 23.97 500 14.68 0.0018
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,220 525 11.18 436 22.82 0.0017
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,695 -1,289 -21.54 355 -32.38 0.0016
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,984 -3,248 -35.18 525 -25.21 0.0023
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,232 7,801 545.14 702 298.86 0.0037
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,431 -1,152 -44.60 176 -19.27 0.0011
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,583 -9,012 -77.72 218 -77.76 0.0017
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,595 -802 -6.47 980 17.22 0.0068
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,397 2,767 28.73 836 1.33 0.0071
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,630 8,832 1,106.77 825 1,061.97 0.0071
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 798 -3,416 -81.06 71 -80.22 0.0006
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,214 1,301 44.66 359 27.30 0.0026
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,913 -196 -6.30 282 -3.75 0.0015
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,109 3,109 293 0.0016
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -5,445 -100.00 0 -100.00
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,445 4,835 792.62 486 752.63 0.0024
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 610 -366 -37.50 57 -35.96 0.0003
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 976 566 138.05 89 147.22 0.0005
2017-05-15 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 410 -2,147 -83.97 36 -83.02 0.0003
2017-02-14 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,557 -613 -19.34 212 -27.65 0.0015
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,170 2,066 187.14 293 240.70 0.0019
2016-08-15 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,104 1,104 0.00 86 0.0006
2016-05-16 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -662 -100.00 0 -100.00
2016-02-16 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 662 45 7.29 69 6.15 0.0007
2015-11-16 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 617 -1,016 -62.22 65 -70.85 0.0006
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,633 1,633 223 0.0022
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 61,100 8.33 3,452 2.98 n/a n/a n/a
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 56,400 77.92 3,352 95.28 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 31,700 -21.34 1,717 -22.53 n/a n/a n/a
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 40,300 -7.57 2,215 -28.13 n/a n/a n/a
2025-05-14 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 43,600 300.00 3,082 330.45 n/a n/a n/a
2025-02-13 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 10,900 81.67 716 70.07 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 6,000 150.00 422 113.71 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 2,400 -84.21 198 -85.15 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 15,200 -18.28 1,328 -25.99 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 18,600 215.25 1,793 243.49 n/a n/a n/a
2023-11-21 2023-09-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 5,900 -92.79 522 -92.64 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 5,900 522 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 81,800 -22.10 7,090 -30.56 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 105,000 43.05 10,210 34.41 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 73,400 129.38 7,596 179.99 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 32,000 -26.10 2,713 -24.39 n/a n/a n/a
2022-08-08 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 43,300 252.03 3,588 278.48 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 12,300 261.76 948 216.00 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 3,400 -54.05 300 -47.55 n/a n/a n/a
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 7,400 572 n/a n/a n/a
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 3,100 -11.43 234 -23.78 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 3,500 25.00 307 44.13 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 2,800 -61.64 213 -76.33 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 7,300 4.29 900 52.03 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 7,000 900.00 592 903.39 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 700 -97.18 59 -96.47 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 24,800 198.80 1,672 135.16 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 8,300 -77.26 711 -78.07 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 36,500 461.54 3,242 486.26 n/a n/a n/a
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 6,500 62.50 553 42.53 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 4,000 388 n/a n/a n/a
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 6,200 520.00 503 440.86 n/a n/a n/a
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 1,000 0.00 93 2.20 n/a n/a n/a
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 1,000 900.00 91 911.11 n/a n/a n/a
2017-05-15 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 100 -50.00 9 -43.75 n/a n/a n/a
2017-02-14 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 200 0.00 16 -11.11 n/a n/a n/a
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 200 -84.62 18 -82.18 n/a n/a n/a
2016-08-15 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 1,300 -38.10 101 -41.28 n/a n/a n/a
2016-05-16 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 2,100 172 n/a n/a n/a
2016-02-16 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-16 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 500 -96.45 53 -97.25 n/a n/a n/a
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 14,100 1,929 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 39,500 912.82 2,231 865.80 n/a n/a n/a
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 3,900 69.57 232 86.29 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 2,300 -51.06 125 -51.94 n/a n/a n/a
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 4,700 -81.42 258 -85.57 n/a n/a n/a
2025-05-14 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 25,300 61.15 1,788 73.42 n/a n/a n/a
2025-02-13 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 15,700 -35.39 1,032 -39.64 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 24,300 -11.31 1,708 -24.26 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 27,400 144.64 2,256 130.57 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 11,200 -31.29 978 -37.75 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 16,300 12.41 1,572 22.54 n/a n/a n/a
2023-11-21 2023-09-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 14,500 -67.99 1,283 -67.35 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 14,500 1,283 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 45,300 42.01 3,927 26.60 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 31,900 -24.05 3,102 -28.65 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 42,000 13.21 4,347 38.19 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 37,100 260.19 3,145 268.27 n/a n/a n/a
2022-08-08 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 10,300 -33.97 854 -29.01 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 15,600 358.82 1,203 301.00 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 3,400 -88.59 300 -86.97 n/a n/a n/a
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 29,800 -5.10 2,303 -12.10 n/a n/a n/a
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 31,400 83.63 2,620 102.94 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 17,100 151.47 1,291 116.61 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 6,800 -74.53 596 -70.65 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 26,700 115.32 2,031 32.83 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 12,400 13.76 1,529 66.02 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 10,900 34.57 921 34.45 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 8,100 -69.66 685 -61.94 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 26,700 -49.05 1,800 -59.89 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 52,400 170.10 4,488 160.48 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 19,400 108.60 1,723 117.55 n/a n/a n/a
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 9,300 -38.00 792 -45.57 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 15,000 87.50 1,455 92.97 n/a n/a n/a
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 8,000 150.00 754 191.12 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 3,200 146.15 259 114.05 n/a n/a n/a
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 1,300 333.33 121 348.15 n/a n/a n/a
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 300 -76.92 27 -76.32 n/a n/a n/a
2017-05-15 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 1,300 -92.07 114 -91.61 n/a n/a n/a
2017-02-14 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 16,400 0.00 1,358 -10.48 n/a n/a n/a
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 16,400 8,100.00 1,517 9,381.25 n/a n/a n/a
2016-08-15 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 200 -50.00 16 -51.52 n/a n/a n/a
2016-05-16 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 400 33.33 33 6.45 n/a n/a n/a
2016-02-16 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 300 -62.50 31 -63.53 n/a n/a n/a
2015-11-16 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 800 -20.00 85 -37.96 n/a n/a n/a
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 1,000 137 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.